Texas Senior Games Opens Registration for 2020 Games, Announces Humana as Top Sponsor

Multi-Sport Competition to Draw 2,000+ Participants from Across Texas SAN ANTONIO–(BUSINESS WIRE)–Registration for the 2020 Texas Senior Games, the multi-sport competition for seniors that will be held March 26 through April 5, 2020, in San Antonio, is now open. For the first time, leading health and well-being company Humana Inc. (NYSE:HUM) will be the games’ … [Read more…]

SOOTHE® Offers Luxurious Gift With Massage Promotions Plus Special Bath Set to Celebrate Valentine’s Day & Weekend (Feb. 13-16)

LOS ANGELES–(BUSINESS WIRE)–#aromatherapy–Because Valentine’s Day becomes even better when there’s a thoughtful gift attached to a luxurious at-home massage, SOOTHE® is offering a complimentary gift with purchase for all Valentine’s Day & Weekend (Feb. 13-16) couples massage bookings made in the U.S. by Feb. 5.* In addition, there is a special bath set that gifts … [Read more…]

Echosens Aligns with Fatty Liver Foundation to Accelerate Screening for Undiagnosed Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

WALTHAM, Mass.–(BUSINESS WIRE)–#NAFLD—Echosens, a high-technology company offering the FibroScan family of products, is proud to support the Fatty Liver Foundation (FLF), a non-profit organization dedicated to fighting fatty liver disease and advocating for ongoing screening of undiagnosed nonalcoholic fatty liver disease (NAFLD) and its more severe form nonalcoholic steatohepatitis (NASH). FLF is raising awareness about … [Read more…]

Strategic Alliance: Health Connect America and Pathway Healthcare

NASHVILLE, Tenn.–(BUSINESS WIRE)–Health Connect America, (www.healthconnectamerica.com) and Pathway Healthcare, LLC (www.pathwayhealthcare.com) are strategically aligning to provide the highest level of care for patients suffering from addiction and dependence. This alliance is genuinely the first integrative model of its kind, where two companies have come together to ensure patients receive necessary medical, behavioral, and case management … [Read more…]

Celularity Announces FDA Clearance of Landmark IND for CYNK-001, an Allogeneic, Off-the-Shelf Cryopreserved NK Cell Therapy

Company to Initiate First U.S. Clinical Investigation of Allogeneic NK Cell Therapy administered Intravenously or Intratumorally in Patients with Glioblastoma Multiforme (GBM) WARREN, N.J.–(BUSINESS WIRE)–Celularity, Inc. (“Celularity” or the “Company”), a clinical-stage company developing allogeneic cellular therapies from human placentas, today announced the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New … [Read more…]

PharmaCyte Biotech Successfully Completes All Release Tests on Clinical Trial Product

LAGUNA HILLS, Calif.–(BUSINESS WIRE)–#INDstatus–PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that both batches of the company’s manufactured clinical trial product have undergone and passed all 10 of the necessary “release tests” required by the U.S. Food … [Read more…]

Roundtrip and Redox Partner to Deliver a Complete View of the Patient Journey to Care Innovators Everywhere

Partnership ensures interoperability with IT systems across care settings for a comprehensive view of patient movement MADISON, Wis.–(BUSINESS WIRE)–Roundtrip, the leading digital transportation marketplace for providers and patients, announced today its strategic partnership with Redox, the leading integration platform for healthcare data exchange. With Redox ensuring total interoperability across healthcare data source systems, Roundtrip can … [Read more…]

Ocuphire Pharma Announces In-License of Phase 2 Oral Small Molecule Drug Candidate for Diabetic Retinopathy and Diabetic Macular Edema from Apexian Pharmaceuticals

APX3330, a First-in-Class Ref-1 Inhibitor for Diabetic Ocular Diseases Affecting the Retina, Added to Ocuphire Portfolio of Ophthalmic Drug Candidates   Data from Two Recently Completed Nyxol® Phase 2b Studies Accepted for Presentation at ARVO 2020 Conference FARMINGTON HILLS, Michigan–(BUSINESS WIRE)–Ocuphire Pharma, Inc., a clinical-stage pharmaceutical company focused on the development and commercialization of therapies to … [Read more…]

Kurin, Inc. Announces Hire of EVP Operations Amid Record Growth

SAN DIEGO–(BUSINESS WIRE)–Kurin Inc., the inventor and manufacturer of 510(k)-cleared and patented Kurin® blood culture collection sets, announced the hiring of Don Canal to the newly created position of Executive Vice President, Operations. “Bringing Mr. Canal into Kurin is an important addition to our company,” said Bob Rogers, CEO of Kurin, Inc. “Demand for Kurin’s … [Read more…]

Collagenase 3, Pipeline Review, H2 2019 – Aquilus Pharmaceuticals Inc, Pfizer Inc & Pharmahungary Group – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Collagenase 3 – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary According to the recently published report ‘Collagenase 3 – Pipeline Review, H2 2019’; Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) pipeline Target constitutes close to 5 molecules. Out of which approximately 4 molecules are … [Read more…]